186 related articles for article (PubMed ID: 10658776)
1. European medical device regulatory law and product liability.
Bright J
J Hosp Infect; 1999 Dec; 43 Suppl():S169-73. PubMed ID: 10658776
[TBL] [Abstract][Full Text] [Related]
2. CE marking--what does it really mean?
Bentley D
J Tissue Viability; 1999 Jan; 9(1):11-5. PubMed ID: 10480978
[TBL] [Abstract][Full Text] [Related]
3. The regulation of medical devices and the role of the Medical Devices Agency.
Jefferys DB
Br J Clin Pharmacol; 2001 Sep; 52(3):229-35. PubMed ID: 11560554
[TBL] [Abstract][Full Text] [Related]
4. New European guidance on borderline products.
Donawa ME;
Med Device Technol; 2009 Sep; 20(5):22, 24-5. PubMed ID: 19852178
[TBL] [Abstract][Full Text] [Related]
5. Review of the Medical Device Directive.
Donawa M
Med Device Technol; 2003 Mar; 14(2):20-3. PubMed ID: 12698694
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceuticals and Medical Devices: FDA Oversight.
White RS;
Issue Brief Health Policy Track Serv; 2018 Dec; 2018():1-42. PubMed ID: 30695853
[No Abstract] [Full Text] [Related]
7. The classification of antiseptic products to be administered to wounds--another borderline case between medicinal products and medical devices?
Kramer A; Kremer J; Assadian O; Schneider I; Dähne H; Schwemmer J; Müller G; Siegmund W; Jäkel C
Int J Clin Pharmacol Ther; 2006 Dec; 44(12):677-92. PubMed ID: 17190379
[TBL] [Abstract][Full Text] [Related]
8. [Requirements for CE-marking of apps and wearables].
Berensmann M; Gratzfeld M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Mar; 61(3):314-320. PubMed ID: 29368120
[TBL] [Abstract][Full Text] [Related]
9. Medical device directive: preparing for the amendments.
Donawa M
Med Device Technol; 2000; 11(1):40-5. PubMed ID: 10915484
[TBL] [Abstract][Full Text] [Related]
10. Post-decision diagnosis: medical device preemption alive and mostly well after Medtronic, Inc. v. Lohr.
Sayler SW; Thomas SM
Ann Health Law; 1997; 6():185-208. PubMed ID: 10184786
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceuticals and medical devices: medical devices. Issue brief.
Berry MD
Issue Brief Health Policy Track Serv; 2012 Dec; ():1-35. PubMed ID: 23297445
[No Abstract] [Full Text] [Related]
12. Pharmaceuticals and Medical Devices: Medical Devices.
Berry MD;
Issue Brief Health Policy Track Serv; 2015 Dec; ():1-64. PubMed ID: 27116798
[No Abstract] [Full Text] [Related]
13. License to maim: federal pre-emption and the Medical Device Amendments of 1976.
Petrella ME
Health Matrix Clevel; 1996; 6(2):349-89. PubMed ID: 10178392
[No Abstract] [Full Text] [Related]
14. European Animal Tissue Directive.
Donawa M
Med Device Technol; 2004; 15(1):28-31. PubMed ID: 14994636
[TBL] [Abstract][Full Text] [Related]
15. European medical device regulation: a new era?
Donawa M
Med Device Technol; 2004 Dec; 15(10):30-1. PubMed ID: 16225282
[TBL] [Abstract][Full Text] [Related]
16. [Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?].
Stordeur S; Vinck I; Neyt M; Van Brabandt H; Hulstaert F
Rev Epidemiol Sante Publique; 2013 Apr; 61(2):105-10. PubMed ID: 23477881
[TBL] [Abstract][Full Text] [Related]
17. Express preemption and premarket approval under the Medical Device Amendments.
Scandaglia GJ; Tully TL
Food Drug Law J; 2004; 59(2):245-64. PubMed ID: 15318395
[No Abstract] [Full Text] [Related]
18. Medical device recalls.
Spencer P; Zakaib GM
Health Law Can; 2001 Aug; 22(1):1-4. PubMed ID: 11550586
[No Abstract] [Full Text] [Related]
19. The medical device directives and their impact on the development and manufacturing of medical implants.
Crisp S
Proc Inst Mech Eng H; 1996; 210(4):233-9. PubMed ID: 9046183
[TBL] [Abstract][Full Text] [Related]
20. Market introduction of innovative high risk medical devices: towards a recast of the directive concerning medical devices.
Vinck I; Hulstaert F; Van Brabandt H; Neyt M; Stordeur S
Eur J Health Law; 2011 Dec; 18(5):477-89. PubMed ID: 22128518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
